FluidForm Bio utilizes patented FRESH™ technology to bioprint living human tissue that incorporates cells and vasculature, enabling effective treatments for various diseases. This technology addresses the need for high-quality, functional tissue for applications in tissue restoration, repair, and cell therapy.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for creating functional human tissues for regenerative medicine and cell therapy face challenges in replicating the complex cellular structures and vascular networks necessary for tissue survival and integration. Traditional tissue engineering techniques often struggle to produce tissues with sufficient scale, complexity, and vascularization for effective therapeutic applications.
Solution
FluidForm Bio leverages its patented FRESH™ (Freeform Reversible Embedding of Suspended Hydrogels) technology to bioprint living human tissues with intricate cellular arrangements and integrated vasculature. This bioprinting approach allows for the creation of three-dimensional tissue constructs that closely mimic native human tissues, enhancing their functionality and therapeutic potential. By incorporating cells and vasculature directly into the bioprinted tissue, FluidForm Bio aims to overcome the limitations of conventional tissue engineering and enable the development of effective treatments for a range of diseases. The FRESH™ technology facilitates the creation of robust, functional tissues suitable for tissue restoration, repair, and advanced cell therapies.
Target Audience
FluidForm Bio's primary customers include pharmaceutical and biotechnology companies focused on developing advanced cell therapies and regenerative medicine solutions, as well as research institutions involved in tissue engineering and bioprinting.
Features
- FRESH™ (Freeform Reversible Embedding of Suspended Hydrogels) bioprinting technology for creating complex 3D tissue structures.
- Capability to incorporate cells and vasculature within bioprinted tissues.
- Production of living human tissue that closely resembles native tissue.
- Scalable tissue engineering for various therapeutic applications.
- Potential for tissue restoration, repair, and cell therapy.